The SLATE study is a Clinical Research Study For Drug-Resistant Temporal Lobe Epilepsy. This study will use the Medtronic VisualaseTM MRI-Guided Laser Ablation system, which is used to perform minimally invasive laser surgery on soft tissue in the body.
VisualaseTM is currently considered an investigational device for treatment of drug- resistant MTLE. The FDA has cleared the use of VisualaseTM in neurosurgery and other surgical specialties.
You have added pages to your clipboard. Please log in or create an account to share them or use later.
You are now being taken to Columbia Neurosurgery's site dedicated to the spine.
Use this button to save pages to your clipboard for future use.OK. Got it.